Roivant Sciences
Roivant Sciences develops and commercializes medicines and technologies by building agile, focused subsidiary companies known as Vants. The company utilizes technology across the discovery and development process to target autoimmune and pulmonary diseases. Its portfolio includes multiple FDA-approved therapies and a pipeline of investigational drugs undergoing clinical trials.
Visit websiteNew York, United States
Biotechnology
Healthcare
Pharmaceuticals
Funding summary
- Total raised
- €1.2B
- Funding rounds
- 2
Investors in Roivant Sciences
Investors on record for Roivant Sciences. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Roivant Sciences?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors